There are errors in [Table S1](#pone.0124893.s001){ref-type="supplementary-material"} of the published paper. Please view the correct [Table S1](#pone.0124893.s001){ref-type="supplementary-material"} here.

There is an error in the Results. The Results should state that twenty of the 44 participants with severe adverse events carried at least one of the candidate predictive markers.
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======================

###### The genotypes at the loci DPYD and TYMP for 44 participants who had grade 3, 4 or 5 adverse events within 12 weeks of starting the chemotherapeutic protocol.

Treatment regimes; 1 = 5-FU as monotherapy; 2 = 5FU in combination chemotherapy; 3 = capecitabine as monotherapy; 4 = capecitabine in combination chemotherapy. For the genotype data; 0 = homozygous for the minor allele; 1 = heterozygous; 2 = homozygous for the major (wild type) allele. The genotypes 1236G\>A and c1129-5923C\>G are in linkage disequilibrium.

LFT; liver function tests.
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Click here for additional data file.
